Qiaojuan Jane Su on Muck Rack

Qiaojuan Jane Su

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Qiaojuan Jane

Contact Qiaojuan Jane, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Genetic predictors of GLP1 receptor agonist weight loss and side effects

|
By Qiaojuan Jane Su, James Ashenhurst, WanWan Xu, Vinh An Tran, R. Ryanne Wu, Catherine H. Weldon, Jingchunzi Shi, Barry W. Hicks, Noura S. Abul-Husn, Stella Aslibekyan, Bertram L. Koelsch, Adam Auton
| Nature Verified
Abstract The development of glucagon-like peptide 1 (GLP1) receptor agonists, including semaglutide and tirzepatide, has transformed the clinical management of overweight and obesity. However, substantial inter-person variability exists in both weight loss efficacy and the incidence of side effects1.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified